High Tower Advisors, LLC Sanofi Transaction History

High Tower Advisors, LLC

  • $61.2 Billion
  • Q1 2024

A detailed history of High Tower Advisors, LLC transactions in Sanofi stock. As of the latest transaction made, High Tower Advisors, LLC holds 284,302 shares of SNY stock, worth $13.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
284,302
Previous 310,967 8.57%
Holding current value
$13.9 Million
Previous $15.5 Million 10.65%
% of portfolio
0.02%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024
SELL
$45.75 - $52.48 $1.22 Million - $1.4 Million
-26,665 Reduced 8.57%
284,302 $13.8 Million
Q4 2023

Feb 12, 2024
SELL
$43.13 - $54.79 $256,968 - $326,438
-5,958 Reduced 1.88%
310,967 $15.5 Million
Q3 2023

Nov 08, 2023
BUY
$50.95 - $55.2 $1.31 Million - $1.42 Million
25,641 Added 8.8%
316,925 $17 Million
Q2 2023

Aug 14, 2023
BUY
$50.45 - $57.18 $2.7 Million - $3.06 Million
53,503 Added 22.5%
291,284 $15.7 Million
Q1 2023

May 11, 2023
BUY
$45.86 - $54.45 $1.29 Million - $1.54 Million
28,226 Added 13.47%
237,781 $12.9 Million
Q4 2022

Feb 08, 2023
BUY
$38.86 - $48.55 $719,220 - $898,563
18,508 Added 9.69%
209,555 $10.1 Million
Q3 2022

Nov 09, 2022
BUY
$37.22 - $100.5 $491,043 - $1.33 Million
13,193 Added 7.42%
191,047 $7.27 Million
Q2 2022

Aug 10, 2022
BUY
$48.99 - $57.46 $562,160 - $659,353
11,475 Added 6.9%
177,854 $9.05 Million
Q1 2022

May 12, 2022
BUY
$48.48 - $53.65 $263,440 - $291,534
5,434 Added 3.38%
166,379 $8.61 Million
Q4 2021

Feb 10, 2022
SELL
$47.07 - $52.35 $628,902 - $699,448
-13,361 Reduced 7.67%
160,945 $8.22 Million
Q3 2021

Nov 12, 2021
BUY
$47.89 - $53.12 $108,087 - $119,891
2,257 Added 1.31%
174,306 $8.36 Million
Q2 2021

Aug 06, 2021
BUY
$49.36 - $54.25 $1.39 Million - $1.52 Million
28,109 Added 19.53%
172,049 $9.07 Million
Q1 2021

May 10, 2021
BUY
$45.46 - $50.51 $1.22 Million - $1.36 Million
26,920 Added 23.0%
143,940 $7.04 Million
Q4 2020

Feb 10, 2021
BUY
$45.3 - $51.62 $990,529 - $1.13 Million
21,866 Added 22.98%
117,020 $5.63 Million
Q3 2020

Nov 13, 2020
BUY
$49.47 - $53.77 $449,632 - $488,715
9,089 Added 10.56%
95,154 $4.87 Million
Q2 2020

Aug 10, 2020
BUY
$42.91 - $52.5 $196,742 - $240,712
4,585 Added 5.63%
86,065 $4.43 Million
Q1 2020

May 21, 2020
SELL
$38.02 - $51.66 $5.03 Million - $6.83 Million
-132,227 Reduced 61.87%
81,480 $3.56 Million
Q4 2019

Feb 14, 2020
BUY
$44.25 - $50.86 $627,642 - $721,398
14,184 Added 7.11%
213,707 $10.8 Million
Q3 2019

Nov 12, 2019
BUY
$40.34 - $46.64 $272,819 - $315,426
6,763 Added 3.51%
199,523 $9.25 Million
Q2 2019

Aug 13, 2019
BUY
$40.43 - $44.3 $462,276 - $506,526
11,434 Added 6.31%
192,760 $8.33 Million
Q1 2019

May 15, 2019
BUY
$40.83 - $45.43 $534,995 - $595,269
13,103 Added 7.79%
181,326 $8.03 Million
Q4 2018

Feb 14, 2019
SELL
$41.48 - $45.59 $83,416 - $91,681
-2,011 Reduced 1.18%
168,223 $7.29 Million
Q3 2018

Nov 09, 2018
SELL
$40.0 - $44.84 $278,280 - $311,951
-6,957 Reduced 3.93%
170,234 $7.59 Million
Q2 2018

Aug 14, 2018
SELL
$37.63 - $41.22 $762,835 - $835,611
-20,272 Reduced 10.27%
177,191 $7.09 Million
Q1 2018

May 15, 2018
BUY
$38.98 - $45.76 $859,547 - $1.01 Million
22,051 Added 12.57%
197,463 $7.91 Million
Q4 2017

Feb 14, 2018
SELL
$42.86 - $50.61 $731,148 - $863,355
-17,059 Reduced 8.86%
175,412 $7.52 Million
Q3 2017

Nov 14, 2017
BUY
$47.04 - $50.34 $1.23 Million - $1.32 Million
26,220 Added 15.77%
192,471 $9.56 Million
Q2 2017

Aug 14, 2017
BUY
N/A
166,251
166,251 $7.96 Million

Others Institutions Holding SNY

# of Institutions
756
Shares Held
236M
Call Options Held
1.27M
Put Options Held
1.57M
View Full List

About Sanofi

SNY Quotes by TradingView
  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $123B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email